Production of Interleukin 15 by Human Colon Cancer Cells Is Associated with Induction of Mucosal Hyperplasia, Angiogenesis, and Metastasis

Clinical Cancer Research

Volumn 9, Issue 13, 2003, Pages 4802-4810

  Kuniyasu, Hiroki ^a   Ohmori, Hitoshi ^a   Sasaki, Takamistu ^a   Sasahira, Tomonori ^a   Yoshida, Kazuhiro ^b   Kitadai, Yasuhiko ^c   Fidler, Isaiah J ^d  

^a NARA MEDICAL UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BASIC FIBROBLAST GROWTH FACTOR; CELL NUCLEUS ANTIGEN; CYCLIN E; DOXORUBICIN; INTERLEUKIN 15; INTERLEUKIN 15 RECEPTOR; INTERLEUKIN 15 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; PROTEIN BAK; PROTEIN BAX; PROTEIN KINASE B; PROTEIN P21; RECEPTOR SUBUNIT; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL GROWTH; CELL HYPERPLASIA; CELL INFILTRATION; CELL PROLIFERATION; CELL STRAIN; CELL STRAIN KM12C; CELL STRAIN KM12SM; CELL SURVIVAL; COLON CANCER; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE WALL; MAJOR CLINICAL STUDY; METASTASIS POTENTIAL; MOUSE; NATURAL KILLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; SERUM; TISSUE INDUCTION;

ANIMALS; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; COLONIC NEOPLASMS; CULTURE MEDIA, CONDITIONED; DISEASE PROGRESSION; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; HYPERPLASIA; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-15; KINETICS; MICE; MICE, INBRED BALB C; MICE, NUDE; MUCOUS MEMBRANE; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RECEPTORS, INTERLEUKIN-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0142219338     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Kuniyasu, H., Oue, N., Shigeishi, H., Ito, R., Kato, Y., Yokozaki, H., and Yasui, W. Prospective study of Ki-67 labeling index in the mucosa adjacent to cancer as a marker for colorectal cancer metastasis. J. Exp. Clin. Cancer Res., 20: 543-548, 2001.
2. Kuniyasu, H., Yasui, W., Shinohara, H., Yano, S., Ellis, L. M., Wilson, M. R., Bucana, C. D., Rikita, T., Tahara, E., and Fidler, I. J. Induction of angiogenesis by hyperplastic colonic mucosa adjacent to colon cancer. Am. J. Pathol., 157: 1523-1535, 2000.
3. Fidler, I. J. Critical determinants of human colon cancer metastasis. In: E. Tahara (ed.), Molecular Pathology of Gastroenterological Cancer, pp. 147-169. Tokyo: Springer-Verlag, 1997.
4. Ferrara, N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog. Horm. Res., 55: 15-35, 2000.
5. Kuniyasu, H., Oue, N., Nakae, D., Tsutsumi, M., Denda, A., Tsujiuchi, T., Yokozaki, H., and Yasui, W. Interleukin-15 expression is associated with malignant potential in colon cancer cells. Pathobiology, 69: 86-95, 2001.
6. Podolsky, D. K. Healing the epithelium: solving the problem from two sides. J. Gastroenterol., 32: 122-126, 1997.
7. Morikawa, K., Walker, S. M., Jessup, M., and Fidler, I. J. In vitro selection of highly metastatic cells from surgical specimens of different primary human colon carcinomas implanted into nude mice. Cancer Res., 48: 1943-1948, 1988.
8. Morikawa, K., Walker, S. M., Nakajima, M., Pathak, S., Jessup, J. M., and Fidler, I. J. Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice. Cancer Res., 48: 6863-6871, 1988.
9. Fidler, I. J. Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev., 10: 229-243, 1991.
10. Kuniyasu, H., Oue, N., Tsutsumi, M., Kubozoe, T., Tahara, E., and Yasui, W. Heparan sulfate enhances invasion by human colon carcinoma cell lines through expression of CD44 variant exon 3. Clin. Cancer Res., 7: 4067-4072, 2001.
11. Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E., Salmon, M., and Lord, J. M. Serine/threonine protein kinases and apoptosis. Exp. Cell Res., 256: 34-41, 2000.
12. Takahashi, Y., Ellis, L. M., Wilson, M. R., Bucana, C. D., Kitadai, Y., and Fidler, I. J. Progressive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice. Oncol. Res., 8: 163-169, 1996.
13. Singh, R. K., Tsan, R., and Radinsky, R. Influence of the host microenvironment on the clonal selection of human colon carcinoma cells during primary tumor growth and metastasis. Clin. Exp. Metastasis. 15: 140-150, 1997.
14. Anderson, D. M., Kumaki, S., Ahdieh, M., Bertles, J., Tometsko, M., Loomis, A., Giri, J., Copeland, N. G., Gilbert, D. J:, Jenkins, N. A., Valentine, V., Shapiro, D. N., Morris, S., W., Park, L. S., and Cosman. E. Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. J. Biol. Chem., 270: 29862-29869, 1995.
15. Bulfone-Pau, S. S., Bulanova, E., Pohl, T., Budagian, V., Durkop, H., Ruckert, R., Kunzendorf, U., Paus, R., and Krause, H. Death deflected: IL-15 inhibits TNF-α-mediated apoptosis in fibroblasts by TRAF2 recruitment to the IL-15Rα chain. FASEB J., 13: 1575-1585, 1999.
16. L and Bcl-2. J. Immunol., 169: 1760-1767, 2002.
17. Tasaki, K., Yoshida, Y., Miyauchi, M., Maeda, T., Takenaga, K., Kouzu, T., Asano, T., Ochiai, T., Sakiyamna, S., and Tagawa, M. Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts. Cancer Gene Ther., 7: 255-261, 2000.
18. Di Carlo, E., Meazza, R., Basso, S., Rosso, O., Comes, A., Gaggero, A., Musiani, P., Santi, L., and Ferrini, S. Dissimilar antitumor reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice. J. Pathol., 191: 193-201, 2000.
19. Gri, G., Chiodoni, C., Gallo, E., Stoppacciaro, A., Liew, F. Y., and Colombo, M. P. Antitumor effect of interleukin (IL)-12 in the absence of endogenous IFN-γ: a role for intrinsic tumor immunogenicity and IL-15. Cancer Res., 62: 4390-4397, 2002.
20. Fehniger, T. A., Cooper, M. A., and Caligiuri, M. A. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev., 13: 169-183, 2002.
21. Villegas, F. R., Coca, S., Villarrubia, V. G., Jimenez, R., Chillon, M. J., Jareno, J., Zuil, M., and Callol, L. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer, 35: 23-28, 2002.
22. Pross, H. F., and Lotzova, E. Role of natural killer cells in cancer. Nat. Immunol., 12: 279-292, 1993.
23. Schantz, S. P., and Ordonez, N. G. Quantitation of natural killer cell function and risk of metastatic poorly differentiated head and neck cancer. Nat. Immunol. Cell Growth Regul., 10: 278-288, 1991.
24. Long, E. O., Barber, D. F., Burshtyn, D. N., Faure, M., Peterson, M., Rajagopalan, S., Renard, V., Sandusky, M., Stebbins, C. C., Wagtmann, N., and Watzl, C. Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158). Immunol. Rev., 181: 223-233, 2001.
25. Blery, M., Olcese, L., and Vivier, E. Early signaling via inhibitory and activating NK receptors. Hum. Immunol., 61: 51-64, 2000.
26. Lanier, L. L. NK cell receptors. Annu. Rev. Immunol., 16: 359-393, 1998.
27. Ryan, J. C., and Seaman, W. E. Divergent functions of lectin-like receptors on NK cells. Immunol. Rev., 155: 79-89, 1997.
28. Hellstrand, K., Brune, M., Naredi, P., Mellqvist, U. H., Hansson, M., Gehlsen, K. R., and Hermodsson, S. Histamine: a novel approach to cancer immunotherapy. Cancer Investig., 18: 347-355, 2000.
29. Castonguay, A., Rioux, N., Duperron, C., and Jalbert, G. Inhibition of lung tumorigenesis by NSAIDS: a working hypothesis. Exp. Lung Res., 24: 605-615, 1998.
30. Ebert, E. C. Inhibitory effects of transforming growth factor-β (TGF-β) on certain functions of intraepithelial lymphocytes. Clin. Exp. Immunol., 115: 415-420, 1999.
31. Hilakivi-Clarke, L., and Dickson, R. B. Stress influence on development of hepatocellular tumors in transgenic mice overexpressing TGF-α. Acta Oncol., 34: 907-912, 1995.
32. Francavilla, A., Vujanovic, N. L., Polimeno, L., Azzarone, A., Iacobellis, A., Deleo, A., Hagiya, M., Whiteside, T. L., and Starzl, T. E. The in vivo effect of hepatotrophic factors augmenter of liver regeneration, hepatocyte growth factor, and insulin-like growth factor-II on liver natural killer cell functions. Hepatology, 25: 411-415, 1997.
33. Bergelson, L. D. Gangliosides and antitumor immunity. Clin. Investig., 71: 590-594, 1993.
34. Cao, S., Troutt, A. B., and Rustum, Y. M. Interleukin 15 protects against toxicity and potentiates antitumor activity of 5-fluorouracil alone and in combination with leucovorin in rats bearing colorectal cancer. Cancer Res., 58: 1695-1699, 1998.
35. Carson, W. E., Giri, J. G., Lindemann, M. J., Linett, M. L., Ahdieh, M., Paxton, R., Anderson, D., Eisenmann, J., Grabstein, K., and Caligiuri, M. A. Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J. Exp. Med., 180: 1395-1403, 1994.
36. Kuniyasu, H., Yasui, W., Kitadai, Y., Yokozaki, H., Ito, H., and Tahara, E. Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem. Biophys. Res. Commun., 189: 227-232, 1992.
37. Yokozaki, H., Ito, M., Yasui, W., Kyo, E., Kuniyasu, H., Kitadai, Y., Tsubouchi, H., Daikuhara, Y., and Tahara, E. Biologic effect of human hepatocyte growth factor on human gastric carcinoma cell lines. Int. J. Oncol., 3: 89-93, 1993.
38. Kuniyasu, H., Abbruzzese, J. L., Cleary, K. R., and Fidler, I. J. Induction of ductal and stromal hyperplasia by basic fibroblast growth factor produced by human pancreatic carcinoma. Int. J. Oncol., 19: 681-685, 2001.